The U.S. Food and Drug Administration approved updated Risk Evaluation and Mitigation Strategy labeling for Travere Therapeutics Inc.'s (NASDAQ: TVTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE